AKT1 and B-cell chronic lymphocytic leukemia: In contrast, activation of the PI3K/AKT pathway in CLL is induced by other well-known stimuli, particularly through B cell receptor signaling [97], while EPHA2 expression in hematopoietic cells is low [91] and its functional role thus questionable.